IL1B and myeloproliferative neoplasm: This research not only highlights the pivotal role of IL-1β-mediated inflammation in facilitating the transition of JAK2V617F-mutated clonal hematopoiesis to MPN but also underscores the potential of targeting IL-1β during the extended preclinical phase of clonal expansion to prevent or delay malignant transformation.